SciELO - Scientific Electronic Library Online

 
vol.140 número1Cerámicas mexicanas para cicatrización de piel índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Gaceta médica de México

versión On-line ISSN 2696-1288versión impresa ISSN 0016-3813

Resumen

MARTINEZ-MEDINA, Miguel A. Effect of Shortened Directly Observerd Treatment on Compliance and Cure Rate of Pulmonary Tuberculosis. Gac. Méd. Méx [online]. 2004, vol.140, n.1, pp.1-6. ISSN 2696-1288.

Objective: To evaluate shortened directly observed treatment (DOTS) for management of pulmonary tuberculosis and to compare its outcomes with self-administered therapy (SAT). Material and Methods: Evaluation of DOTS, implemented since 1998, was compared with a cohort of pulmonary tuberculosis patients under SAT from 1992 to 1997. Efficacy and efficiency of treatment were evaluated to agree with the National Tuberculosis Control Program. The study was conducted at a primary health care center in Hermosillo, Sonora, Mexico. Results: One hundred thirty eight patients with smear-positive pulmonary tuberculosis were included, 45 in DOTS cohort and 93 in SAT Efficiency was higher in DOTS-managed cases compared with SA T cohort (95.5% vs 76.3%), p <0.05. Indeed, efficiency was significantly higher in relapsed patients treated under DOTS, p <0.05. The non-compliance rate declined to 0.0% in the DOTS cohort. Twenty six percent of DOTS patients were supervised as outpatients. Conclusions: Implementation of DOTS was a flexible and effective strategy in treatment of pulmonary tuberculosis. DOTS allows treatment completion, decline in non-compliance, and increase in care rate.

Palabras llave : Pulmonary tuberculosis; directly observed therapy/DOTS; Mexico.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons